CCDC50: A Protein Target for Cancer and Cardiovascular Diseases

Target Name: CCDC50

NCBI ID: G152137

CCDC50

CCDC50: A Protein Target for Cancer and Cardiovascular Diseases

CCDC50, also known as CCDC50A or CDK5A, is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as the brain, heart, and gastrointestinal tract.

In recent years, researchers have been interested in studying CCDC50 as a potential drug target or biomarker. This is because the protein is involved in many important cellular processes that are important for human health, and because it is often expressed at high levels in cancer cells.

One of the key reasons why CCDC50 is being studied as a potential drug target is its role in cell signaling. CCDC50 is a key regulator of the TGF-β signaling pathway, which is involved in the development and maintenance of tissues. TGF-β signaling is important for many different processes in the body, including cell growth, differentiation, and survival.

Research has shown that changes in the levels of CCDC50 can be associated with the development of many different types of cancer, including breast, ovarian, and prostate cancers. This is because the TGF-β signaling pathway is often disrupted in cancer cells, and this can lead to the development of uncontrolled cell growth and the formation of tumors.

Another reason why CCDC50 is being studied as a potential drug target is its role in cancer cell migration. Cancer cells are able to migrate from the primary tumor to other parts of the body, where they can establish new tumors. CCDC50 is involved in the migration of cancer cells along the blood vessels that supply these cells.

Research has shown that changes in the levels of CCDC50 can also be associated with the development of certain cardiovascular diseases, such as heart failure and hypertension. This is because the TGF-β signaling pathway is often disrupted in these conditions, and this can lead to the development of uncontrolled cell growth and the formation of plaque in the arteries.

In addition to its role in cancer and cardiovascular diseases, CCDC50 is also being studied as a potential biomarker. This is because the protein is often expressed at high levels in a variety of tissues, including cancer cells, and can be used as a marker for the presence of these cells.

Overall, CCDC50 is a protein that is involved in many important cellular processes that are important for human health. As a result, it is an attractive target for drug development, both as a potential drug target and as a biomarker. Further research is needed to fully understand the role of CCDC50 in these processes, and to develop safe and effective treatments for the prevention and treatment of diseases associated with its dysfunction.

Protein Name: Coiled-coil Domain Containing 50

Functions: Involved in EGFR signaling

The "CCDC50 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC50 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets